Assessing the performance of amorphous solid dispersions.
about
Fundamental aspects of solid dispersion technology for poorly soluble drugsIn vitro and in vivo evaluation of amorphous solid dispersions generated by different bench-scale processes, using griseofulvin as a model compound.Molecular interaction studies of amorphous solid dispersions of the antimelanoma agent betulinic acidTowards improved solubility of poorly water-soluble drugs: cryogenic co-grinding of piroxicam with carrier polymers.Impact of Micellar Surfactant on Supersaturation and Insight into Solubilization Mechanisms in Supersaturated Solutions of Atazanavir.Summary of the National Institute of Child Health and Human Development-best pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop-Pediatric Biopharmaceutics Classification System Working Group.Characterization of supersaturatable formulations for improved absorption of poorly soluble drugs.Physical stabilization of low-molecular-weight amorphous drugs in the solid state: a material science approach.Amorphous solid dispersions: a robust platform to address bioavailability challenges.Understanding pharmaceutical polymorphic transformations II: crystallization variables and influence on dosage forms.Evaluation of the Microcentrifuge Dissolution Method as a Tool for Spray-Dried Dispersion.Influence of Copolymer Composition on In Vitro and In Vivo Performance of Celecoxib-PVP/VA Amorphous Solid Dispersions.Rational excipient selection for co-amorphous formulations.Oral bioavailability enhancement through supersaturation: an update and meta-analysis.The improved dissolution performance of a post processing treated spray-dried crystalline solid dispersion of poorly soluble drugs.Physical Properties and Effect in a Battery of Safety Pharmacology Models for Three Structurally Distinct Enteric Polymers Employed as Spray-Dried Dispersion Carriers.The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane.Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.Screening methodologies for the development of spray-dried amorphous solid dispersions.Evaluation of the recrystallization kinetics of hot-melt extruded polymeric solid dispersions using an improved Avrami equation.DNP-enhanced solid-state NMR spectroscopy of active pharmaceutical ingredients.35Cl dynamic nuclear polarization solid-state NMR of active pharmaceutical ingredients.Introductory lecture: Mechanochemistry, a versatile synthesis strategy for new materials.Solubility and dissolution enhancement strategies: current understanding and recent trends.A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.Investigation of process temperature and screw speed on properties of a pharmaceutical solid dispersion using corotating and counter-rotating twin-screw extruders.Preparation and characterization of Simvastatin solid dispersion using skimmed milk.Insights into Nano- and Micron-Scale Phase Separation in Amorphous Solid Dispersions Using Fluorescence-Based Techniques in Combination with Solid State Nuclear Magnetic Resonance Spectroscopy
P2860
Q26822873-9E369DFA-200B-41A3-9FC7-F3BCB7566246Q34605997-3D552CD0-0EDD-49D8-8D1F-CED61A8C703AQ35209956-7063159A-DB95-406B-B079-3EE92E7C85B8Q35660913-D4606E41-CC58-4254-9A7B-465C9534171BQ36326329-30AE1043-EFF3-4A67-A6AE-594D63623776Q36501845-142BAF53-3C3A-4A76-9F9C-72D164BDAE99Q38026509-BEAAE765-515E-40D2-80AF-F8AB41F90EE4Q38257177-4C43C311-FB48-4335-AC0F-82F9CD00AD98Q38358879-680D5FF0-12B9-4570-9C91-2B962AA1558AQ38543393-6583C45F-2F29-43ED-AFF7-F95EFB3703C6Q38790553-CD5F8436-B697-4B8A-9A32-28550C950368Q38790753-0F282F4F-7CE8-400B-BDEE-B0F9769EFF9CQ38856865-A322D5C6-A7AE-4F24-B0B0-7833EBAD9916Q38917369-85DE2673-F13F-4C32-8E5D-B9E6B5EE5738Q39860106-4C3A1B7B-6756-436F-9270-9F96D36CF4FEQ41446416-37B5B8B3-8350-45FC-84A6-3BF72644EF3BQ41986961-433AD068-1838-46AF-AF90-C2231F4F974BQ42104195-BABAACE5-99F2-484B-A518-07556D807B80Q44690013-01900904-47AF-4515-86EE-88960AEC0BDFQ45326562-12CA504D-A9BB-4597-9EC4-786F4E6C8FAAQ47807784-EB83653D-3302-470E-A987-35EA1696CE8AQ48486066-7E52D0BD-4F0D-4AD8-93B3-C8F6F81C8E90Q48520512-E9F0DDEA-341A-42B2-A9AC-3A9A4FA2B564Q51020710-3EF1E4A6-AA68-4219-8259-FB999FE33DF2Q53305176-7F85015C-515F-4DCE-A954-8245487DFD6AQ54037823-DEEE15E1-621A-41A3-98DD-E9452BEC08BFQ54695491-8E0C1BFB-BB35-4666-9C44-25AB5662A85EQ57351454-6128DA3B-19A4-4AA9-887B-94910B6EA5D8
P2860
Assessing the performance of amorphous solid dispersions.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Assessing the performance of amorphous solid dispersions.
@en
Assessing the performance of amorphous solid dispersions.
@nl
type
label
Assessing the performance of amorphous solid dispersions.
@en
Assessing the performance of amorphous solid dispersions.
@nl
prefLabel
Assessing the performance of amorphous solid dispersions.
@en
Assessing the performance of amorphous solid dispersions.
@nl
P2093
P356
P1476
Assessing the performance of amorphous solid dispersions.
@en
P2093
Ann Newman
George Zografi
Gregory Knipp
P304
P356
10.1002/JPS.23031
P407
P577
2011-12-27T00:00:00Z